Note Regarding Forward-looking Statements



This report, including "Part I - Item 2. Management's Discussion and Analysis of
Financial Condition and Results of Operations" and "Part II - Item 1A. Risk
Factors" contains certain forward-looking statements that involve risks and
uncertainties, including statements regarding our strategy, financial
performance and revenue sources. We use words such as "anticipate," "believe,"
"can," "continue," "could," "expect," "future," "intend," "plan," and similar
expressions to identify forward-looking statements. Our actual results could
differ materially from the results anticipated in these forward-looking
statements as a result of certain factors including those set forth under "Risk
Factors," beginning at page   37   and elsewhere in this Form 10-Q. Although we
believe that the expectations reflected in the forward-looking statements are
reasonable, we cannot guarantee future results, levels of activity, performance
or achievements. You should not place undue reliance on these forward-looking
statements. We disclaim any obligation to update information contained in any
forward-looking statement. These forward-looking statements include, without
limitation, statements regarding the following:
•Our expectation that certain supply chain constraints will continue through
calendar 2022 and into calendar 2023;
•That local governments could require us or our suppliers to reduce production,
cease operations, or implement mandatory vaccine requirements, and we could
experience constraints in fulfilling customer orders;
•Our expectation that we will experience period-to-period fluctuations in
operating results due to general industry or economic conditions;
•The effects that uncertain global economic conditions and fluctuations in the
global credit and equity markets may have on our financial condition and results
of operations;
•The effects and amount of competitive pricing pressure on our product lines and
modest pricing declines in certain of our more mature proprietary product lines;
•Our ability to moderate future average selling price declines;
•The effect of product mix, capacity utilization, yields, fixed cost absorption,
competition and economic conditions on gross margin;
•The amount of, and changes in, demand for our products and those of our
customers;
•The impact of national security protections, trade restrictions and changes in
tariffs, including those impacting China;
•Our expectation that in the future we will acquire additional businesses that
we believe will complement our existing businesses;
•Our expectation that in the future we will enter into joint development
agreements or other strategic relationships with other companies;
•The level of orders that will be received and shipped within a quarter,
including the impact of our product lead times;
•Our goal to continue to be more efficient with our selling, general and
administrative expenses;
•Our expectation that our days of inventory at December 31, 2022 will be 143 to
147 days;
•Our belief that customers recognize our products and brand name and use
distributors as an effective supply channel;
•The accuracy of our estimates of the useful life and values of our property,
assets and other liabilities;
•Our ability to increase the proprietary portion of our analog product line and
the effect of such an increase;
•The impact of any supply disruption we may experience;
•Our ability to effectively utilize our facilities at appropriate capacity
levels;
•The likelihood of our stock price to fluctuate in the future;
•Our ability to maintain manufacturing yields;
•The maintenance of our competitive position based on our investments in new and
enhanced products;
•The success of our licensing business depending on the continued market
acceptance of our technologies and on our ability to further develop such
technologies and to introduce new technologies;
•The potential of the Preferred Supply Program and the long-term supply
agreements to satisfy commitments to our suppliers, enable us to forecast
capital equipment requirements and employee needs, ramp up manufacturing and
manufacture products more efficiently;
•The cost effectiveness of using our own assembly and test operations;
•The greater functionality in new product designs afforded by our proprietary
design and manufacturing processes;
•Our plans to continue to transition certain outsourced assembly and test
capacity to our internal facilities;
•Our expectation of continued investment in expanding our manufacturing capacity
through calendar 2022 and during the next twelve months;
•The continued development of the embedded control market based on our strong
technical service presence;
                                       24
--------------------------------------------------------------------------------
  Table of Contents
•Our expectation that foundry capacity will continue to be limited due to strong
demand for wafers across the industry;
•Our expectation that we will continue to operate our manufacturing facilities
at or above normal capacity if the current supply constraints relative to demand
continue;
•Our anticipated level of capital expenditures;
•The continuation and amount of quarterly cash dividends;
•The sufficiency of our existing sources of liquidity to finance anticipated
capital expenditures and otherwise meet our anticipated cash requirements, and
the effects that our contractual obligations are expected to have on them;
•Our belief that the capital expenditures to be incurred over the next twelve
months will provide sufficient manufacturing capacity to support the growth of
our production capabilities for our new products and technologies and to bring
in-house more of the production requirements that are currently outsourced;
•The impact of seasonality on our business;
•Our belief that our IT system compromise has not had a material adverse effect
on our business or resulted in any material damage to us;
•Our expectation that we will continue to be the target of cyber-attacks,
computer viruses, unauthorized access and other attempts to breach or otherwise
compromise the security of our IT systems and data;
•The impact of the resolution of legal actions on our business, and the accuracy
of our assessment of the probability of loss and range of potential loss;
•Our plans to pursue all available administrative and judicial remedies
necessary to resolve the Statutory Notice of Deficiency we received;
•Our expectation regarding the treatment of our unrecognized tax benefits in
calendar year 2022;
•Our belief that the expiration of any tax holidays will not have a material
impact on our effective tax rate;
•The impact of the geographical dispersion of our earnings and losses on our
effective tax rate;
•Our belief that the estimates used in preparing our condensed consolidated
financial statements are reasonable;
•Our actions to vigorously and aggressively defend and protect our intellectual
property on a worldwide basis;
•Our ability to obtain patents and intellectual property licenses and minimize
the effects of litigation;
•The level of risk we are exposed to for product liability claims or
indemnification claims;
•The effect of fluctuations in market interest rates on our income and/or cash
flows;
•The effect of fluctuations in currency rates;
•Our ability to increase our borrowings or seek additional equity or debt
financing to maintain or expand our facilities, or to fund cash dividends, share
repurchases, acquisitions or other corporate activities, and that the timing and
amount of such financing requirements will depend on a number of factors;
•Our expectations regarding the amounts and timing of repurchases under our
stock repurchase program;
•Our expectation that our reliance on third-party contractors may increase over
time as our business grows;
•Our ability to collect accounts receivable;
•The impact of the legislative and policy changes implemented or which may be
implemented by the current administration, on our business and the trading price
of our stock;
•Our plans to continue to undertake efforts to conform to current regulatory
obligations and evolving best practices;
•Our plans to continue to comply with applicable U.S. sanctions regarding
Ukraine;
•The costs we expect to incur associated with certain disclosure requirements;
•Estimates and plans regarding pension liability and payments expected to be
made for benefits earned; and
•The impact on our business stemming from Russia's invasion of Ukraine.

Our actual results could differ materially from the results anticipated in these
forward-looking statements as a result of certain factors including those set
forth in "Item 1A. Risk Factors," and elsewhere in this Form 10-Q. Although we
believe that the expectations reflected in our forward-looking statements are
reasonable, we cannot guarantee future results, levels of activity, performance
or achievements. You should not place undue reliance on these forward-looking
statements. We disclaim any obligation to update the information contained in
any forward-looking statement.

                                       25
--------------------------------------------------------------------------------
  Table of Contents
Introduction

The following discussion should be read in conjunction with the condensed consolidated financial statements and the related notes that appear elsewhere in this document.



We begin our Management's Discussion and Analysis of Financial Condition and
Results of Operations with a summary of business and macroeconomic developments
followed by a summary of our overall business strategy to give the reader an
overview of the goals and overall direction of our business. This is followed by
a discussion of the Critical Accounting Policies and Estimates that we believe
are important to understanding the assumptions and judgments incorporated in our
reported financial results. We then discuss our Results of Operations for the
three and six months ended September 30, 2022 compared to the three and six
months ended September 30, 2021, followed by an analysis of changes in our
balance sheet and cash flows, and discuss our financial commitments in the
section titled "Liquidity and Capital Resources."

Business and Macroeconomic Environment



The COVID-19 pandemic initially resulted in a global disruption in economic
activity by adversely affecting production, creating supply chain and market
disruption, and adversely impacting businesses and individuals. However, in the
second half of fiscal 2021, business conditions were unexpectedly strong as
businesses and individuals adapted to the effects of the pandemic. In response
to global supply constraints, we worked to mitigate the impact of the pandemic
on our business by qualifying alternative suppliers, increasing our inventory of
raw materials, ramping our internal factories and adding assembly and test
capacity to increase our manufacturing capability while securing additional
capacity with our subcontractors wherever possible. However, strong customer
demand continued to outpace capacity in the first six months of fiscal 2023 and
in fiscal 2022 as we continued to experience constraints in our internal and
external factories and their related manufacturing supply chains. We expect that
certain supply chain constraints will persist through calendar 2022 and into
calendar 2023; however, recent uncertainty in the U.S. and world economies may
lessen the impact of such constraints in future periods. In addition, rising
interest rates and high inflation in the U.S. may result in a slowdown in the
economy and reduce customer demand in our industry. We are unable to predict the
timing or impact of any such slowdown on our business.

In order to provide prioritized capacity to our customers, we launched our
Preferred Supply Program in February 2021, which provides our customers with
prioritized capacity beginning six months after the customer places an order for
12 months of continuous, non-cancellable and non-reschedulable backlog. In the
first three quarters of calendar 2022, we entered into certain long-term supply
agreements with our customers for products that will be shipped in future
periods. We also entered into certain long-term supply agreements with key
suppliers.

In response to the pandemic, we have taken proactive preventative measures to
enable a safe environment for our employees and operation of our manufacturing
sites. While our global manufacturing sites have been fully operational in
recent periods, we strategically implemented plans intended to provide more
assurance of business continuity in the event severe outbreaks or government
requirements were to impact our operations.

Strategy



We develop, manufacture and sell smart, connected and secure embedded control
solutions used by our customers for a wide variety of applications. Our
strategic focus includes general purpose and specialized 8-bit, 16-bit, and
32-bit microcontrollers, microprocessors, analog, FPGA, and memory products.
With over 30 years of technology leadership, our broad product portfolio is a
Total System Solution (TSS) for our customers that can provide a large portion
of the silicon requirements in their applications. TSS is a combination of
hardware, software and services which help our customers increase their revenue,
reduce their costs and manage their risks compared to other solutions. Our
synergistic product portfolio empowers disruptive growth trends, including 5G,
data centers, artificial intelligence and machine learning, Internet of Things
(IoT) and edge computing, advanced driver assist systems (ADAS) and autonomous
driving, and electric vehicles, in key end markets such as automotive, aerospace
and defense, communications, consumer appliances, data centers and computing,
and industrial.

                                       26
--------------------------------------------------------------------------------
  Table of Contents
Our manufacturing operations include wafer fabrication, wafer probe, assembly
and test. The ownership of a substantial portion of our manufacturing resources
is an important component of our business strategy, enabling us to maintain a
high level of manufacturing control, resulting in us being one of the lowest
cost producers in the embedded control industry. By owning wafer fabrication
facilities and our assembly and test operations, and by employing statistical
techniques (statistical process control, designed experiments and wafer level
monitoring), we have been able to achieve and maintain high production
yields. Direct control over manufacturing resources allows us to shorten our
design and production cycles. This control also allows us to capture a portion
of the wafer manufacturing and assembly and testing profit margin. We outsource
a significant portion of our manufacturing requirements to third parties and the
amount of our outsourced manufacturing has increased in recent years due to our
acquisitions of Microsemi and other companies that outsourced all or substantial
portions of their manufacturing. In light of our manufacturing strategy and
potential grant funding from the CHIPS Act, as well as state and local grants
and subsidies, we are in the early stages of considering building a 300 mm U.S.
based wafer fabrication facility for specialized, trailing edge technologies.
This project, if we decide to pursue it, would be intended to provide
competitive growth capacity, as well as geographic and geopolitical
diversification. The availability of grants, subsidies and other incentives will
all be important considerations in our analysis and will also help determine the
location and timing for the facility.

We employ proprietary design and manufacturing processes in developing our
embedded control products. We believe our processes afford us both
cost-effective designs in existing and derivative products and greater
functionality in new product designs. While many of our competitors develop and
optimize separate processes for their logic and memory product lines, we use a
common process technology for both microcontroller and non-volatile memory
products. This allows us to more fully leverage our process research and
development costs and to deliver new products to market more rapidly. Our
engineers utilize advanced computer-aided design tools and software to perform
circuit design, simulation and layout, and our in-house photomask and wafer
fabrication facilities enable us to rapidly verify design techniques by
processing test wafers quickly and efficiently.

We are committed to continuing our investment in new and enhanced products,
including development systems, and in our design and manufacturing process
technologies. We believe these investments are significant factors in
maintaining our competitive position. Our current research and development
activities focus on the design of new microcontrollers, digital signal
controllers, memory, analog and mixed-signal products, FPGAs, timing systems,
Flash-IP, development systems, software and application-specific software
libraries. We are also developing new design and process technologies to achieve
further cost reductions and performance improvements in our products.

We market and sell our products worldwide primarily through a network of direct
sales personnel and distributors. Our direct sales force focuses on a wide
variety of strategic accounts in three geographical markets: the Americas,
Europe and Asia. We currently maintain sales and technical support centers in
major metropolitan areas in all three geographic markets. We believe that a
strong technical service presence is essential to the continued development of
the embedded control market. Many of our CEMs, ESEs, and sales managers have
technical degrees or backgrounds and have been previously employed in high
technology environments. We believe that the technical and business knowledge of
our sales force is a key competitive advantage in the sale of our products. The
primary mission of our ESE team is to provide technical assistance to customers
and to conduct periodic training sessions for the balance of our sales
team. ESEs also frequently conduct technical seminars and workshops in major
cities around the world or through online webcasts. Our licensing division has
dedicated sales, technology, design, product, test and reliability personnel
that support the requirements of our licensees.

See the risk factor captioned "Our operating results are impacted by seasonality
and wide fluctuations of supply and demand in the industry" on page   43   for
discussion of the impact of seasonality on our business.

Critical Accounting Policies and Estimates



Except for the changes discussed in "Recently Adopted Accounting Pronouncements"
in Note 2 to our condensed consolidated financial statements in this Form 10-Q,
there were no changes to our critical accounting policies and estimates during
the first six months of the fiscal year ending March 31, 2023 compared to our
"Critical Accounting Policies and Estimates" as previously described in Part II,
Item 7 of our Annual Report on Form 10-K for the fiscal year ended March 31,
2022.

                                       27
--------------------------------------------------------------------------------
  Table of Contents
Results of Operations

The following table sets forth certain operational data as a percentage of net sales for the periods covered by this report:



                                            Three Months Ended September 30,                Six Months Ended September 30,
                                                                                            2022                      2021                     2022                     2021
Net sales                                                                                       100.0  %                 100.0  %                 100.0  %                 100.0  %
Cost of sales                                                                                    32.6                     35.2                     32.9                     35.5
Gross profit                                                                                     67.4                     64.8                     67.1                     64.5

Research and development                                                                         13.0                     14.9                     13.3                     15.1
Selling, general and
administrative                                                                                    9.8                     10.9                      9.7                     11.0
Amortization of acquired
intangible assets                                                                                 8.0                     13.2                      8.3                     13.4
Special charges (income) and
other, net                                                                                        0.2                      0.6                     (0.3)                     0.6
Operating income                                                                                 36.4  %                  25.2  %                  36.1  %                  24.4  %



Net Sales

We operate in two industry segments and engage primarily in the design,
development, manufacture and sale of semiconductor products as well as the
licensing of our SuperFlash and other technologies. We sell our products to
distributors and OEMs in a broad range of markets, perform ongoing credit
evaluations of our customers and generally require no collateral. In certain
circumstances, a customer's financial condition may require collateral, and, in
such cases, the collateral would be typically provided in the form of letters of
credit.

The following table summarizes our net sales for the periods covered by this report (dollars in millions):



                                                                    Three Months Ended September 30,                            Six Months Ended 

September 30,


                                                               2022                2021             Change                 2022                  2021             Change
Net sales                                                  $  2,073.2          $ 1,649.8              25.7  %       $       4,036.8          $ 3,219.2              25.4  %



The increases in net sales in the three and six months ended September 30, 2022
compared to the three and six months ended September 30, 2021 were primarily due
to strong business conditions that began in the second half of fiscal 2021 as
businesses and individuals adapted to the effects of the COVID-19 pandemic.
Business conditions continued to be strong in the three and six months ended
September 30, 2022 although there is increased uncertainty as to the future
direction of the U.S. economy due to rising interest rates and high inflation.
Additionally, semiconductor industry conditions have resulted in increased costs
throughout our supply chain, which we have been passing on to our customers in
the form of price increases. These price increases also contributed to the
increase in net sales during the three and six months ended September 30, 2022
compared to the three and six months ended September 30, 2021. Our price
increases were implemented at various times and in various amounts throughout
fiscal 2022 with respect to our very broad range of customers and products. Due
to the complexity of the implementation of the price increases and the changes
in product, geographic and customer mix, we are not able to quantify the impact
of the price increases on our net sales. Additionally, the increase in net sales
was positively impacted by strength in all of our product lines.

Other factors that we believe contributed to changes in our reported net sales
for the three and six months ended September 30, 2022 compared to the three and
six months ended September 30, 2021 and which are drivers of long-term trends in
our net sales but which factors we are not able to quantify include:
•semiconductor industry conditions;
•our various new product offerings that have increased our served available
market;
•customers' increasing needs for the flexibility offered by our programmable
solutions; and
•increasing semiconductor content in our customers' products through our Total
Systems Solutions.

We sell a large number of products to a large and diverse customer base and there was not any single product or customer that accounted for a material portion of the change in our net sales in the three and six months ended September 30, 2022 or the three and six months ended September 30, 2021.


                                       28
--------------------------------------------------------------------------------
  Table of Contents
Net sales by product line for the periods covered by this report were as follows
(dollars in millions):

                                      Three Months Ended September 30,                           Six Months Ended September 30,

                                                                                              2022                 %                 2021                 %                 2022                 %                 2021                 %
Microcontrollers                                                                          $ 1,179.5                56.9          $   894.0                54.1          $ 2,242.5                55.6          $ 1,796.5                55.8
Analog                                                                                        572.5                27.6              490.9                29.8            1,152.5                28.5              923.0                28.7
Other                                                                                         321.2                15.5              264.9                16.1              641.8                15.9              499.7                15.5
Total net sales                                                                           $ 2,073.2               100.0          $ 1,649.8               100.0          $ 4,036.8               100.0          $ 3,219.2               100.0



Microcontrollers

Our microcontroller product line represents the largest component of our total
net sales. Microcontrollers and associated application development systems
accounted for approximately 56.9% and 55.6% of our net sales for the three and
six months ended September 30, 2022, respectively, compared to approximately
54.1% and 55.8% of our net sales for the three and six months ended September
30, 2021, respectively.

Net sales of our microcontroller products increased 31.9% and 24.8% in the three
and six months ended September 30, 2022, respectively, compared to the three and
six months ended September 30, 2021. These sales increases were due primarily to
strength in demand for our microcontroller products in end markets that we serve
and our price increases.

Historically, average selling prices in the semiconductor industry decrease over
the life of any particular product. However, the overall average selling prices
of our microcontroller products have increased in recent periods and have
remained relatively stable over time due to the proprietary nature of these
products. We have in the past been able to, and expect in the future to be able
to, moderate average selling price declines in our microcontroller product lines
by introducing new products with more features and higher prices.

Analog



Our analog product line includes analog, interface, mixed signal and timing
products. Our analog product line accounted for approximately 27.6% and 28.5% of
our net sales for the three and six months ended September 30, 2022,
respectively, compared to approximately 29.8% and 28.7% of our net sales for the
three and six months ended September 30, 2021, respectively.

Net sales from our analog product line increased 16.6% and 24.9% in the three
and six months ended September 30, 2022, respectively, compared to the three and
six months ended September 30, 2021, primarily due to strength in demand for our
analog products in end markets that we serve and our price increases.

We consider a majority of the products in our analog product line to be proprietary in nature, where prices are relatively stable, similar to the pricing stability experienced in our microcontroller products. The non-proprietary portion of our analog product line will experience price fluctuations, driven primarily by the current supply and demand for those products.

Other



Our other product line includes FPGA products, royalties associated with
licenses for the use of our SuperFlash and other technologies, sales of our
intellectual property, fees for engineering services, memory products, timing
systems, manufacturing services (wafer foundry and assembly and test
subcontracting), legacy application specific integrated circuits, and certain
products for aerospace applications. Revenue from these services and products
accounted for approximately 15.5% and 15.9% of our net sales for the three and
six months ended September 30, 2022, respectively, compared to approximately
16.1% and 15.5% of our net sales for the three and six months ended September
30, 2021, respectively.

Net sales related to these services and products increased 21.3% and 28.4% in
the three and six months ended September 30, 2022, respectively, compared to the
three and six months ended September 30, 2021. The increases in net sales were
primarily due to strength in demand for our products in end markets that we
serve and our price increases. Net sales of our other product line can fluctuate
over time based on general economic and semiconductor industry conditions as
well as changes in demand for our FPGA products, licenses, engineering services,
memory products, and manufacturing services (wafer foundry and assembly and test
subcontracting).

                                       29
--------------------------------------------------------------------------------
  Table of Contents
Distribution

Distributors accounted for approximately 46% of our net sales in each of the
three and six months ended September 30, 2022, compared to approximately 50% of
our net sales in each of the three and six months ended September 30, 2021. The
decreases in the distribution percentage of our total net sales were due to
lower Preferred Supply Program participation among our distributors as priority
of supply under the Preferred Supply Program is more prevalent with direct
customers. With the exception of Arrow Electronics, our largest distributor,
which made up 10% of our net sales, no other distributor or end customer
accounted for more than 10% of our net sales in the six months ended September
30, 2022. In the six months ended September 30, 2021, no distributor or end
customer accounted for more than 10% of our net sales. Our distributors focus
primarily on servicing the product requirements of a broad base of diverse
customers. We believe that distributors provide an effective means of reaching
this broad and diverse customer base. We believe that customers recognize
Microchip for its products and brand name and use distributors as an effective
supply channel.

Generally, we do not have long-term agreements with our distributors and we, or
our distributors, may terminate our relationships with each other with little or
no advance notice, with the exception of orders placed under our Preferred
Supply Program or otherwise designated as non-cancellable.  The loss of, or the
disruption in the operations of, one or more of our distributors could reduce
our future net sales in a given quarter and could result in an increase in
inventory returns.

At September 30, 2022, our distributors maintained 19 days of inventory of our
products compared to 17 days at March 31, 2022. Over the past ten fiscal years,
the days of inventory maintained by our distributors have fluctuated between
approximately 17 days and 40 days. Inventory holding patterns at our
distributors may have a material impact on our net sales. Our distributor
inventory days are near historic lows due to the imbalance between the supply of
and the demand for our products in the current supply-constrained environment.

Sales by Geography

Sales by geography for the periods covered by this report were as follows (dollars in millions):



                                      Three Months Ended September 30,                           Six Months Ended September 30,
                                                                                              2022                %                 2021                %                 2022                %                 2021                %
Americas                                                                                  $   525.1               25.3          $   419.8               25.4          $ 1,021.3               25.3          $   792.9               24.6
Europe                                                                                        415.8               20.1              324.6               19.7              813.4               20.1              634.3               19.7
Asia                                                                                        1,132.3               54.6              905.4               54.9            2,202.1               54.6            1,792.0               55.7
Total net sales                                                                           $ 2,073.2              100.0          $ 1,649.8              100.0          $ 4,036.8              100.0          $ 3,219.2              100.0



Americas sales include sales to customers in the U.S., Canada, Central America
and South America. Sales to foreign customers accounted for approximately 78% of
our total net sales in each of the three and six months ended September 30, 2022
compared to approximately 77% and 78% of our total net sales in the three and
six months ended September 30, 2021, respectively. Substantially all of our
foreign sales are U.S. dollar denominated. Sales to customers in Europe as a
percentage of total net sales increased in the three and six months ended
September 30, 2022 compared to the three and six months ended September 30, 2021
primarily due to strength in demand in our microcontroller and analog product
lines. Our sales force in the Americas and Europe supports a significant portion
of the design activity for products which are ultimately shipped to Asia.

Gross Profit



Our gross profit in the three months ended September 30, 2022 was $1.40 billion,
or 67.4% of net sales, compared to $1.07 billion, or 64.8% of net sales, in the
three months ended September 30, 2021. Our gross profit in the six months ended
September 30, 2022 was $2.71 billion, or 67.1% of net sales, compared to $2.08
billion, or 64.5% of net sales, in the six months ended September 30, 2021.
Gross margin increased in the three and six months ended September 30, 2022
compared to the three and six months ended September 30, 2021 primarily as a
result of higher utilization of our factories due to increased customer demand.

Our overall inventory levels were $1.03 billion at September 30, 2022, compared
to $854.4 million at March 31, 2022. We maintained 139 days of inventory on our
balance sheet at September 30, 2022 compared to 125 days of inventory at March
31, 2022. Inventory increased primarily as a result of our efforts to balance
manufacturing production, demand and inventory levels. Our inventory levels are
impacted by the timing of receipt of raw materials and foundry wafers,
fulfilling
                                       30
--------------------------------------------------------------------------------
  Table of Contents
sales demand, and variations between our forecasted and actual demand. We expect
our days of inventory levels at December 31, 2022 to be 143 to 147 days.

We operate assembly and test facilities in Thailand, the Philippines, and other
locations throughout the world. Approximately 59% of our assembly requirements
were performed in our internal assembly facilities during each of the three and
six months ended September 30, 2022 and September 30, 2021. During the three and
six months ended September 30, 2022, approximately 69% and 67%, respectively, of
our test requirements were performed in our internal test facilities, compared
to approximately 64% during the three and six months ended September 30, 2021.
The percentage of our assembly and test operations that are performed internally
fluctuates over time based on supply and demand conditions in the semiconductor
industry, our internal capacity capabilities and our acquisition activities. We
believe that the assembly and test operations performed at our internal
facilities provide us with significant cost savings compared to third party
contractor assembly and test costs, as well as increased control over these
portions of the manufacturing process. We plan to continue to invest in assembly
and test equipment to increase our internal capacity capabilities and transition
certain outsourced assembly and test capacity to our internal facilities.

We rely on outside wafer foundries for a significant portion of our wafer
fabrication requirements. Approximately 63% of our net sales came from products
that were produced at outside wafer foundries in each of the three and six
months ended September 30, 2022, compared to 60% and 59% in the three and six
months ended September 30, 2021, respectively.

Research and Development



R&D expenses for the three months ended September 30, 2022 were $268.6 million,
or 13.0% of net sales, compared to $246.2 million, or 14.9% of net sales, for
the three months ended September 30, 2021. R&D expenses for the six months ended
September 30, 2022 were $537.6 million, or 13.3% of net sales, compared to
$484.6 million, or 15.1% of net sales, for the six months ended September 30,
2021. We are committed to investing in new and enhanced products, including
development systems software, and in our design and manufacturing process
technologies. We believe these investments are significant factors in
maintaining our competitive position. R&D costs are expensed as incurred. Assets
purchased to support our ongoing research and development activities are
capitalized when related to products which have achieved technological
feasibility or that have alternative future uses and are amortized over their
expected useful lives. R&D expenses include labor, depreciation, masks,
prototype wafers, and expenses for the development of process technologies, new
packages, and software to support new products and design environments.

R&D expenses increased $22.4 million, or 9.1%, for the three months ended
September 30, 2022 over the same period last year.  R&D expenses increased $53.0
million, or 10.9%, for the six months ended September 30, 2022 over the same
period last year. The primary reasons for the increases in R&D costs were
increases in employee compensation and higher product development costs.

R&D expenses fluctuate over time, primarily due to revenue and operating expense investment levels.

Selling, General and Administrative



Selling, general and administrative expenses for the three months ended
September 30, 2022 were $202.4 million, or 9.8% of net sales, compared to $179.9
million, or 10.9% of net sales, for the three months ended September 30, 2021.
Selling, general and administrative expenses for the six months ended September
30, 2022 were $391.3 million, or 9.7% of net sales, compared to $354.2 million,
or 11.0% of net sales, for the six months ended September 30, 2021.  Our goal is
to continue to be more efficient with our selling, general and administrative
expenses. Selling, general and administrative expenses include salary expenses
related to field sales, marketing and administrative personnel, advertising and
promotional expenditures and legal expenses as well as costs related to our
direct sales force, CEMs and ESEs who work remotely from sales offices worldwide
to stimulate demand by assisting customers in the selection and use of our
products.

Selling, general and administrative expenses increased $22.5 million, or 12.5%,
for the three months ended September 30, 2022 over the same period last year.
Selling, general and administrative expenses increased $37.1 million, or 10.5%,
for the six months ended September 30, 2022 over the same period last year. 

The

primary reason for the increases in selling, general and administrative expenses was increases in employee compensation.

Selling, general and administrative expenses fluctuate over time, primarily due to revenue and operating expense investment levels.


                                       31
--------------------------------------------------------------------------------
  Table of Contents
Amortization of Acquired Intangible Assets

Amortization of acquired intangible assets for the three and six months ended
September 30, 2022 was $167.5 million and $335.1 million, respectively, compared
to $215.7 million and $431.3 million for the three and six months ended
September 30, 2021, respectively. The primary reason for the decreases in
acquired intangible asset amortization was due to the use of accelerated
amortization methods for assets placed in service in previous fiscal years.

Special Charges (Income) and Other, Net



During the three months ended September 30, 2022, we incurred special charges
and other, net of $4.3 million. During the six months ended September 30, 2022,
we incurred special income and other, net of $12.6 million. During the three and
six months ended September 30, 2021, we incurred special charges and other, net
of $10.2 million and $20.7 million, respectively. The income incurred was
primarily related to the favorable resolution of a previously accrued legal
matter and the remaining charges incurred were primarily related to
restructuring of acquired and existing wafer fabrication operations to increase
operational efficiency.

Other Income (Expense)

Interest income in the three and six months ended September 30, 2022 was $0.2 million and $0.3 million, respectively, compared to $0.1 million and $0.4 million, respectively, for the three and six months ended September 30, 2021.



Interest expense in the three and six months ended September 30, 2022 was $53.3
million and $103.6 million, respectively, compared to $64.8 million and $137.1
million, respectively, for the three and six months ended September 30, 2021.
The primary reasons for the decreases in interest expense relates to the
adoption of ASU 2020-06 on April 1, 2022, which eliminated the amortization of
debt discount on our Convertible Debt, and the cumulative pay down of our debt
offset by higher interest rates on our outstanding variable rate debt.

During the three and six months ended September 30, 2022, we recognized losses
of $2.1 million and $8.3 million, respectively, related to the settlement of a
portion of our outstanding 2015 Senior Convertible Debt, our 2017 Senior
Convertible Debt, and our 2017 Junior Convertible Debt. During the three and six
months ended September 30, 2021, we recognized losses of $85.2 million and $85.5
million, respectively, related to the settlement of a portion of our outstanding
2015 Senior Convertible Debt, our 2017 Senior Convertible Debt, and our 2017
Junior Convertible Debt as well as the repayment of $1.00 billion aggregate
principal amount outstanding of our 3.922% 2021 Notes.

Other loss, net in the three months ended September 30, 2022 was $0.8 million
compared to $1.6 million for the three months ended September 30, 2021. Other
income, net in the six months ended September 30, 2022 was $0.9 million compared
to other loss, net of $1.1 million for the six months ended September 30, 2021.

Provision for Income Taxes



Our provision or benefit for income taxes is attributable to U.S. federal,
state, and foreign income taxes. A comparison of our tax rates for the six
months ended September 30, 2022 and September 30, 2021 is not meaningful due to
the amount of pre-tax income, and income tax expense recorded during the prior
period.

We are subject to taxation in many jurisdictions in which we have operations.
The effective tax rates that we pay in these jurisdictions vary widely, but they
are generally lower than our combined U.S. federal and state effective tax rate.
Our domestic blended statutory tax rate in each of the six months ended
September 30, 2022 and September 30, 2021 was approximately 22%. Our non-U.S.
blended statutory tax rates in the six months ended September 30, 2022 and
September 30, 2021 were lower than this amount. The difference in rates
applicable in foreign jurisdictions results from a number of factors, including
lower statutory rates, tax holidays, financing arrangements and other factors.
Our effective tax rate has been and will continue to be impacted by the
geographical dispersion of our earnings and losses.

Our foreign tax rate differential benefit primarily relates to our operations
and assets in Thailand, Malta, and Ireland. Our Thailand manufacturing
operations are currently subject to numerous tax holidays granted to us based on
our investment in property, plant, and equipment in Thailand. Our tax holiday
periods in Thailand expire at various times in the future; however, we actively
seek to obtain new tax holidays, otherwise we will be subject to tax at the
statutory tax rate of 20%. We do not expect the future expiration of any of our
tax holiday periods in Thailand to have a material impact on our effective tax
rate.  The remaining material components of foreign income taxed at a rate lower
than the U.S. are earnings accrued in Ireland at a 12.5% statutory tax rate and
earnings accrued in Malta at a 5.0% statutory tax rate.
                                       32

--------------------------------------------------------------------------------

Table of Contents



In September 2021, we received a Statutory Notice of Deficiency (Notice) from
the Internal Revenue Service (IRS) for fiscal 2007 through fiscal 2012. The
disputed amounts largely relate to transfer pricing matters. We firmly believe
that the assessments are without merit and plan to pursue all available
administrative and judicial remedies necessary to resolve this matter. In
December 2021, we filed a petition in the United States Tax Court challenging
the Notice. We intend to vigorously defend our position and we are confident in
our ability to prevail on the merits. We regularly assess the likelihood of
adverse outcomes resulting from examinations such as this to determine the
adequacy of our tax reserves. We believe that the final adjudication of this
matter will not have a material impact on our consolidated financial position,
results of operations or cash flows and that we have adequate tax reserves for
all tax matters. However, the ultimate outcome of disputes of this nature is
uncertain, and if the IRS were to prevail on all of its assertions, the assessed
tax, penalties, and deficiency interest could have a material adverse impact on
our financial position, results of operations or cash flows.

Various taxing authorities in the U.S. and other countries in which we do
business are increasing their scrutiny of the tax structures employed by
businesses. Companies of our size and complexity are regularly audited by the
taxing authorities in the jurisdictions in which they conduct significant
operations. For U.S. federal, and in general for U.S. state tax returns, our
fiscal 2007 and later tax returns remain effectively open for examination by the
taxing authorities. We are currently being audited by the tax authorities in the
U.S. and in various foreign jurisdictions. At this time, we do not know what the
outcome of these audits will be. We record benefits for uncertain tax positions
based on an assessment of whether it is more likely than not that the tax
positions will be sustained based on their technical merits under currently
enacted law. If this threshold is not met, no tax benefit of the uncertain tax
position is recognized. If the threshold is met, we recognize the largest amount
of the tax benefit that is more than 50% likely to be realized upon ultimate
settlement.

In August 2022, the U.S. government enacted the Inflation Reduction Act of 2022
(Inflation Reduction Act) into law. The Inflation Reduction Act includes a new
corporate alternative minimum tax (Corporate AMT) of 15% on the adjusted
financial statement income (AFSI) of corporations with average AFSI exceeding
$1.00 billion over a three-year period. The Corporate AMT is effective for us
beginning in fiscal 2024. We are evaluating the Corporate AMT and its potential
impact on our future U.S. tax expense, cash taxes, and effective tax rate.
Additionally, the Inflation Reduction Act imposes a 1% excise tax on the fair
market value of net stock repurchases made after December 31, 2022. We are
evaluating the excise tax and its potential impact on our future U.S. tax
expense, cash taxes, and effective tax rate.


                                       33
--------------------------------------------------------------------------------
  Table of Contents
Liquidity and Capital Resources

We had $306.8 million in cash, cash equivalents and short-term investments at September 30, 2022, a decrease of $12.6 million from the March 31, 2022 balance.

Operating Activities



Net cash provided by operating activities was $1.63 billion in the six months
ended September 30, 2022, primarily due to higher net income of $1.05 billion,
adjusted for non-cash and non-operating charges of $739.3 million and net cash
outflows of $159.1 million from changes in our operating assets and liabilities.
The primary drivers of the changes in operating assets and liabilities in the
six months ended September 30, 2022 include an increase in trade accounts
receivable driven primarily by higher net sales and an increase in inventories
related to increased production levels and higher costs of materials and
production costs in support of customer demand for our products, offset by
increases in accrued and other liabilities driven by higher sales related
reserves. Net cash provided by operating activities was $1.24 billion in the six
months ended September 30, 2021, primarily due to net income of $494.8 million,
adjusted for non-cash and non-operating charges of $763.0 million and net cash
outflows of $16.2 million from changes in our operating assets and liabilities.

Investing Activities



Net cash used in investing activities was $284.6 million in the six months ended
September 30, 2022 compared to $208.7 million in the six months ended September
30, 2021. During the six months ended September 30, 2022 and September 30, 2021,
net investing activities primarily related to capital purchases and investments
in other assets.

Our level of capital expenditures varies from time to time as a result of actual
and anticipated business conditions. Capital expenditures in the six months
ended September 30, 2022 were $232.2 million compared to $164.8 million in the
six months ended September 30, 2021. Capital expenditures were primarily for the
expansion of production capacity and the addition of research and development
equipment. Towards the second half of fiscal 2021, we started to invest more
significantly to expand our manufacturing capacity in response to supply
constraints relative to current demand levels and we expect this to continue
through calendar 2022. We currently expect to invest between $500 million and
$600 million in equipment and facilities during the next twelve months. We
believe that the capital expenditures anticipated to be incurred over the next
twelve months will provide sufficient manufacturing capacity to support the
growth of our production capabilities for our new products and technologies and
to bring in-house more of our production requirements that are currently
outsourced. We expect to finance our capital expenditures through our existing
cash balances and cash flows from operations.  In August 2022, the U.S.
government enacted the CHIPS Act which is to provide billions of dollars of cash
incentives and a new investment tax credit to increase domestic manufacturing
capacity in our industry. Such incentives may potentially be available to us,
our competitors and foundries; however, there can be no assurance that we will
receive any such incentives, what the amount and timing of any incentive we
receive will be, as to which other companies will receive incentives and whether
the legislation will have a positive or negative impact on our competitive
position.

Financing Activities



Net cash used in financing activities was $1.36 billion in the six months ended
September 30, 2022 compared to $1.06 billion in the six months ended September
30, 2021. Significant transactions affecting our net financing cash flows
included:
•in the first six months of fiscal 2023, $597.4 million of cash used to pay down
certain principal of our debt, including our 2015 Senior Convertible Debt, our
2017 Senior Convertible Debt, our 2017 Junior Convertible Debt, and our
Revolving Credit Facility, and
•in the first six months of fiscal 2022, $806.6 million of cash used to pay down
certain principal of our debt, including the cash portion of the settlement of
our 2015 Senior Convertible Debt, our 2017 Senior Convertible Debt and our 2017
Junior Convertible Debt, our Revolving Credit Facility and our 3.922% 2021
Notes, partially funded by the issuance of our senior notes, and
•in the first six months of fiscal 2023 and fiscal 2022, we paid cash dividends
to our stockholders of $319.1 million and $234.3 million, respectively, and
•in the first six months of fiscal 2023, we repurchased shares of our common
stock for $442.4 million.

In December 2021, we amended and restated our Credit Agreement in its entirety.
The amended and restated Credit Agreement provides for an unsecured revolving
loan facility up to $2.75 billion that terminates on December 16, 2026. The
Credit Agreement also permits us, subject to certain conditions, to add one or
more incremental term loan facilities or increase the revolving loan commitments
up to $750.0 million. As of September 30, 2022, the principal amount of our
                                       34
--------------------------------------------------------------------------------
  Table of Contents
outstanding indebtedness was $7.34 billion. At September 30, 2022, we had $972.1
million of outstanding borrowings under the Revolving Credit Facility compared
to $1.40 billion at March 31, 2022.

Capital Returns



In November 2021, our Board of Directors authorized the repurchase of up to
$4.00 billion of our common stock in the open market or in privately negotiated
transactions. In the first six months of fiscal 2023, we repurchased
approximately 6.5 million shares of our common stock for $442.4 million under
this authorization. We did not repurchase any shares of our common stock in the
first six months of fiscal 2022. As of September 30, 2022, approximately $3.13
billion remained available for repurchases under the program. As of
September 30, 2022, we held approximately 27.8 million shares as treasury
shares. Our current intent is to regularly repurchase shares of our common stock
over time based on our cash generation, leverage metrics, and market conditions.

In October 2002, we announced that our Board of Directors had approved and
instituted a quarterly cash dividend on our common stock. To date, our
cumulative dividend payments have totaled approximately $5.36 billion. A
quarterly cash dividend of $0.301 per share was paid on September 2, 2022 in the
aggregate amount of $166.1 million. A quarterly dividend of $0.328 per share was
declared on November 3, 2022 and will be paid on December 6, 2022 to
stockholders of record as of November 22, 2022. We expect the aggregate cash
dividend for the December 2022 quarter to be approximately $181.0 million. Our
Board is free to change our dividend practices at any time and to increase or
decrease the dividend paid, or not to pay a dividend on our common stock on the
basis of our results of operations, financial condition, cash requirements and
future prospects, and other factors deemed relevant by our Board. Our current
intent is to increase our quarterly cash dividends depending upon market
conditions, our results of operations, and potential changes in tax laws.

We believe that our existing sources of liquidity combined with cash generated
from operations and borrowings under our Revolving Credit Facility will be
sufficient to meet our currently anticipated cash requirements for at least the
next 12 months. Our long-term liquidity requirements primarily arise from
working capital requirements, interest and principal repayments related to our
outstanding indebtedness, capital expenditures, cash dividends, share
repurchases, and income tax payments. For additional information regarding our
cash requirements see "Note 11. Commitments and Contingencies", "Note 7. Debt"
and "Note 12. Income Taxes" of the notes to our condensed consolidated financial
statements. The semiconductor industry is capital intensive and in order to
remain competitive, we must constantly evaluate the need to make significant
investments in capital equipment for both production and research and
development and to expand our existing facilities or potentially construct new
facilities. We may increase our borrowings under our Revolving Credit Facility
or seek additional equity or debt financing from time to time to maintain or
expand our wafer fabrication and product assembly and test facilities, for cash
dividends, for share repurchases or for acquisitions or other purposes. The
timing and amount of any such financing requirements will depend on a number of
factors, including our level of dividend payments, changes in tax laws and
regulations regarding the repatriation of offshore cash, demand for our
products, changes in industry conditions, product mix, competitive factors and
our ability to identify suitable acquisition candidates. We may from time to
time seek to refinance certain of our outstanding notes or Convertible Debt
through issuances of new notes or convertible debt, tender offers, exchange
transactions or open market repurchases. Such issuances, tender offers or
exchanges or purchases, if any, will depend on prevailing market conditions, our
ability to negotiate acceptable terms, our liquidity position and other factors.
There can be no assurance that any financing will be available on acceptable
terms due to uncertainties resulting from rising interest rates, higher
inflation, economic uncertainty, the COVID-19 pandemic, or other factors, and
any additional equity financing would result in incremental ownership dilution
to our existing stockholders. We also plan to pursue incentives under the CHIPS
Act to increase our domestic manufacturing capacity; however, there can be no
assurance that we will receive any such incentives or what the amount and timing
of any incentive we receive will be.

© Edgar Online, source Glimpses